UNSPSC 51102902: Atovaquone/proguanil

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AP101. This VA Drug Class (AP101) classifies this compound as belonging to the group ANTIMALARIALS.

UNSPSC 51102902 Atovaquone/proguanil, a Commodity code, shows minimal relevant recent state and local procurement activity. The code nominally covers a specific antimalarial pharmaceutical, but the recent opportunities posted under this code—naloxone procurement, direct-to-manufacturer pharmacy programs, medical and first aid supplies, and generic multi-source pharmaceuticals—do not align with atovaquone/proguanil sourcing. The opportunities reflect broader state and local health agency purchasing of emergency medical supplies, pharmacy benefit programs, and generic pharmaceutical product categories rather than targeted procurement of this specific active pharmaceutical ingredient or finished drug form.

The mismatch between the code's nominal scope and actual recent solicitation content suggests either tagging inconsistency within state and local procurement systems or that atovaquone/proguanil sourcing is not an active category for state and local health agencies at present. No recent opportunities specifically identify demand for atovaquone/proguanil as a line item or deliverable. Business development professionals should verify whether this code reflects historical purchasing patterns or whether health agencies in their target jurisdictions source this pharmaceutical through broader generic pharmaceutical contracts, cooperative purchasing agreements such as MMCAP, or direct-to-wholesaler relationships outside formal competitive solicitation.